Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bellway reiterates guidance but reports subdued autumn activity

(Sharecast News) - Shares in Bellway fell sharply on Tuesday despite the UK housebuilder reporting strong growth for the first half and reiterating its full-year guidance, as the firm highlighted the "sensitivity of customer demand" amid a rise in mortgage rates over recent months Bellway said total housing completions were 4,577 homes in the six months to 31 January, up 11.9% on last year, with the average selling price rising to £310,600 from £309,278. Housing revenues increased by 12% to £1.42bn.

However, the builder said it did not experience the typical seasonal step-up in reservations during the autumn, though reservation rates for the half as a whole were up 14.3% at 160 per week.

The builder said it was on track to deliver volume output of at least 8,500 homes over the 12 months to 31 July, up from 7,654 homes last year, with output weighted towards the first half.

Looking ahead, Bellway said the forward order book stood at 4,726 homes by 31 January, up from 3,970 at the time point last year, with a vale of £1.131bn, up from £1.01bn.

"While we have been encouraged by a seasonal pick-up in customer enquiries and reservation rates in the early weeks of the current spring selling season, we remain mindful of the sensitivity of customer demand to mortgage affordability and the evolving economic backdrop," the company said.

The stock was down 6.3% at 2,402p by 0809 GMT. Prior to Tuesday, shares have risen by nearly a fifth since hitting a 52-week closing low of 2,170p on 13 January.

Share this article

Related Sharecast Articles

Arecor enters collaboration with unnamed global pharma major
(Sharecast News) - Arecor Therapeutics announced on Wednesday that it has entered into a new collaboration with a major global pharmaceutical company to apply its proprietary Arestat technology platform to develop an enhanced formulation of the partner's proprietary product.
Deutsche Bank downgrades Wetherspoons to 'sell'
(Sharecast News) - Deutsche Bank downgraded its stance on shares of pub group JD Wetherspoon to 'sell' from 'neutral' on Wednesday, slashing the price target to 450p from 600p following interim results.
Keras reports progress at Falcon Isle, appoints managing director
(Sharecast News) - Keras Resources reported continued operational progress at its wholly-owned Falcon Isle Resources subsidiary in Utah on Wednesday, alongside the appointment of Colton Hale as managing director.
GameStop surges on plan to buy Bitcoin
(Sharecast News) - GameStop surged in pre-market trade on Wednesday after the video game retailer said it plans to buy Bitcoin.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.